MNDL Bio
@mndl.bio
MNDL Bio is building the predictive engine for scalable protein production. AI has accelerated protein discovery - but manufacturing remains one of biotech’s biggest bottlenecks. Companies still spend years in costly trial-and-error cycles trying to achieve stable, high-yield protein expression at industrial scale. We replace that uncertainty with software. Our AI-powered engineering engine combines mechanistic biophysical modeling with generative algorithms to design full genetic construct architecture - not just codon optimization. We engineer manufacturability at the DNA level, improving the probability of high, stable expression before expensive scale-up and CMC processes begin. Built on 15+ years of research led by our CSO, Prof. Tamir Tuller, our proprietary models form a defensible scientific core, strengthened by a growing real-world data flywheel. We work with biotech, biopharma, enzyme, and synthetic biology teams to: • Increase protein yield • Reduce development timelines • Lower scale-up risk • Improve production robustness MNDL Bio is a scalable software platform designed for enterprise deployment across global protein development pipelines. Predictable biology starts with engineered DNA.
MNDL Bio's Company Logos
MNDL Bio's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#FF00FF
Magenta / Fuchsia
255, 0, 255
300, 100, 50
0, 100, 0, 0
#FFFFFF
White
255, 255, 255
0, 0, 100
0, 0, 0, 0
#000000
Black
0, 0, 0
0, 0, 0
0, 0, 0, 100
About MNDL Bio
MNDL Bio is a pioneering synthetic biology company dedicated to revolutionizing the food and biotech industries. With a focus on reducing costs and production time, we utilize advanced computational tools to optimize gene expression. Our cutting-edge technology, developed from 15 years of academic research at Tuller's Lab, harnesses the power of artificial intelligence and machine learning to drive innovation in synthetic biology.
At MNDL Bio, we believe in unlocking nature's potential for a brighter future. Our team, led by CEO Steve Grun and CSO Prof. Tamir Tuller, combines their expertise to propel us forward.
With several proof-of-concept projects under our belt, we have already made significant strides towards optimizing gene expression. Join us on this exciting journey towards a more sustainable and efficient future. Stay up-to-date with our latest developments and be the first to know about our upcoming breakthroughs by subscribing to our newsletter.
Together, let's shape the future of synthetic biology
Company type
Privately Held
Year founded
2023
Company size
2-10 employees
